Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 2
1957 1
1961 2
1968 1
1971 3
1973 1
1976 1
1978 2
1980 1
1981 2
1982 4
1983 4
1985 1
1986 1
1987 2
1988 1
1989 2
1991 3
1992 3
1993 1
1995 4
1996 3
1997 1
1998 1
1999 2
2001 2
2003 4
2004 4
2005 1
2006 1
2007 3
2008 2
2009 3
2010 11
2011 5
2012 7
2013 4
2014 10
2015 17
2016 8
2017 13
2018 11
2019 11
2020 19
2021 19
2022 23
2023 18
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
This study is registered at ClinicalTrials.gov, number NCT02358031. FINDINGS: Between April 20, 2015, and Jan 17, 2017, 882 participants were allocated to receive pembrolizumab alone (n=301), pembrolizumab with chemotherapy (n=281), or cetuximab with chemotherapy (n=300); …
This study is registered at ClinicalTrials.gov, number NCT02358031. FINDINGS: Between April 20, 2015, and Jan 17, 2017, 882 participa …
HIV silencing and cell survival signatures in infected T cell reservoirs.
Clark IC, Mudvari P, Thaploo S, Smith S, Abu-Laban M, Hamouda M, Theberge M, Shah S, Ko SH, Pérez L, Bunis DG, Lee JS, Kilam D, Zakaria S, Choi S, Darko S, Henry AR, Wheeler MA, Hoh R, Butrus S, Deeks SG, Quintana FJ, Douek DC, Abate AR, Boritz EA. Clark IC, et al. Nature. 2023 Feb;614(7947):318-325. doi: 10.1038/s41586-022-05556-6. Epub 2023 Jan 4. Nature. 2023. PMID: 36599978 Free PMC article.
Ex Vivo Study of Laban's Role in Decreasing Hemolysis Crisis in G6PD-Deficient Patients.
Zam W, Belal L. Zam W, et al. J Nutr Metab. 2020 Jan 21;2020:8034672. doi: 10.1155/2020/8034672. eCollection 2020. J Nutr Metab. 2020. PMID: 32051767 Free PMC article.
This decrease was correlated with a high antioxidant capacity of Laban (51.61 1.13% expressed by the percentage inhibition of DPPH radical). ...In conclusion, the synergy between the antioxidant properties of Laban and the possible decrease of vicine and convicine c …
This decrease was correlated with a high antioxidant capacity of Laban (51.61 1.13% expressed by the percentage inhibition of DPPH ra …
Assessing the reliability of the Laban Movement Analysis system.
Bernardet U, Fdili Alaoui S, Studd K, Bradley K, Pasquier P, Schiphorst T. Bernardet U, et al. PLoS One. 2019 Jun 13;14(6):e0218179. doi: 10.1371/journal.pone.0218179. eCollection 2019. PLoS One. 2019. PMID: 31194794 Free PMC article.
The Laban Movement Analysis system (LMA) is a widely used system for the description of human movement. ...This research advances the state of the art in formalizing and implementing a reliability measure for the Laban Movement Analysis system. The experimental stud …
The Laban Movement Analysis system (LMA) is a widely used system for the description of human movement. ...This research advances the …
Physical, chemical, microbial, and sensory evaluation and fatty acid profiling of value-added drinking yogurt (laban) under various storage conditions.
Junaid M, Inayat S, Gulzar N, Khalique A, Shahzad F, Irshad I, Imran M. Junaid M, et al. J Dairy Sci. 2023 Jan;106(1):39-46. doi: 10.3168/jds.2022-22358. Epub 2022 Nov 7. J Dairy Sci. 2023. PMID: 36357201 Free article.
The acidity of laban increased with storage time. Bacteria, including coliforms, were not found in any treatment group during storage. In conclusion, overall acceptability of laban prepared from buffalo milk was higher than that made from cow milk or mixed milk, but …
The acidity of laban increased with storage time. Bacteria, including coliforms, were not found in any treatment group during storage …
Draft Genome Sequences of Probiotic Candidate Schleiferilactobacillus harbinensis Isolated from Fermented Milk "Laban".
Mashraqi A, Eshetea BB, Eribo B. Mashraqi A, et al. Microbiol Resour Announc. 2023 Jan 24;12(1):e0104322. doi: 10.1128/mra.01043-22. Epub 2022 Dec 6. Microbiol Resour Announc. 2023. PMID: 36472459 Free PMC article.
This study reports the whole-genome sequence of Schleiferilactobacillus harbinensis isolated from laban, indigenous fermented milk of Saudi Arabia. The genome sequence is 3,023,618 bp long, has 179 contigs, and has a G+C content of 53.3%....
This study reports the whole-genome sequence of Schleiferilactobacillus harbinensis isolated from laban, indigenous fermented milk of …
230 results